Cameroon vs Cote d'Ivoire: Population requiring preventive chemotherapy for schistosomiasis
Cameroon
6.80 million
in 2024
Cote d'Ivoire
8.30 million
in 2024
Cameroon rank
12th
Cote d'Ivoire rank
10th
Population requiring preventive chemotherapy for schistosomiasis over time
- Cameroon
- Cote d'Ivoire
How they compare
Cote d'Ivoire currently reports 8.30 million against 6.80 million in Cameroon, a difference of 1.51 million.
That makes Cote d'Ivoire's figure about 1.2 times Cameroon's.
The two have swapped places 7 times across 15 shared years of data; in 2010 it was Cameroon ahead.
Cameroon ranks 12th and Cote d'Ivoire ranks 10th of 52 countries.
Across the 2 decades both report, Cameroon averaged higher in 1 and Cote d'Ivoire in 1.
Head to head by decade
| Decade | Cameroon | Cote d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.46 million | 4.22 million | 2.24 million | Cameroon |
| 2020s | 6.02 million | 6.94 million | 923,046 | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Cameroon or Cote d'Ivoire?
- Cote d'Ivoire, at 8.30 million against 6.80 million in Cameroon as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Cameroon and Cote d'Ivoire?
- 1.51 million, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cameroon and Cote d'Ivoire?
- 15 years are reported by both, from 2010 to 2024.
- How do Cameroon and Cote d'Ivoire rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Cameroon ranks 12th and Cote d'Ivoire ranks 10th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.